AU2002230888A1 - Methods and compositions to treat conditions associated with neovascularization - Google Patents

Methods and compositions to treat conditions associated with neovascularization

Info

Publication number
AU2002230888A1
AU2002230888A1 AU2002230888A AU3088802A AU2002230888A1 AU 2002230888 A1 AU2002230888 A1 AU 2002230888A1 AU 2002230888 A AU2002230888 A AU 2002230888A AU 3088802 A AU3088802 A AU 3088802A AU 2002230888 A1 AU2002230888 A1 AU 2002230888A1
Authority
AU
Australia
Prior art keywords
neovascularization
compositions
methods
conditions associated
treat conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230888A
Inventor
Kin-Ping Wong
Caiyao Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wackvom Ltd
Original Assignee
Wackvom Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wackvom Ltd filed Critical Wackvom Ltd
Publication of AU2002230888A1 publication Critical patent/AU2002230888A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002230888A 2000-12-15 2001-12-14 Methods and compositions to treat conditions associated with neovascularization Abandoned AU2002230888A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25587600P 2000-12-15 2000-12-15
US60/255,876 2000-12-15
PCT/US2001/048520 WO2002047673A2 (en) 2000-12-15 2001-12-14 Methods and compositions to treat conditions associated with neovascularization

Publications (1)

Publication Number Publication Date
AU2002230888A1 true AU2002230888A1 (en) 2002-06-24

Family

ID=22970220

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230888A Abandoned AU2002230888A1 (en) 2000-12-15 2001-12-14 Methods and compositions to treat conditions associated with neovascularization

Country Status (7)

Country Link
US (1) US6608107B2 (en)
EP (1) EP1343487A2 (en)
JP (1) JP2005502579A (en)
CN (1) CN100490791C (en)
AU (1) AU2002230888A1 (en)
MY (1) MY134562A (en)
WO (1) WO2002047673A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385936A (en) 1990-07-12 1995-01-31 The United States Of America As Represented By The Secretary Of The Department Of The Health And Human Services Gossypol acetic acid for the treatment of cancer
US7427689B2 (en) * 2000-07-28 2008-09-23 Georgetown University ErbB-2 selective small molecule kinase inhibitors
US7432304B2 (en) * 2001-05-30 2008-10-07 The Regents Of The University Of Michigan Small molecule antagonists of Bcl-2 family proteins
AU2002360335A1 (en) * 2001-11-01 2003-05-12 The Regents Of The University Of Michigan Small molecule inhibitors targeted at bcl-2
CN100413493C (en) * 2003-06-11 2008-08-27 中国科学院动物研究所 Use of gossypol and its derivative in preparation of drug for leukemia / bone marrow cancer
ES2351581T3 (en) * 2003-06-25 2011-02-08 The Burnham Institute APOGOSIPOL ANALOGS FOR USE IN THE TREATMENT OF CANCER.
JP4390809B2 (en) * 2004-01-07 2009-12-24 イーエルシー マネージメント エルエルシー Cosmetic composition and method for hair growth retardation
CN1960719B (en) * 2004-03-25 2011-12-07 密执安州立大学董事会 Gossypol co-crystals and the use thereof
US20110091552A1 (en) * 2007-08-31 2011-04-21 Mccaffrey Tim Use of Bcl Inhibitors for the Treatment of Scarring Caused By Cutaneous Wounds, Burns and Abrasions
JP5406194B2 (en) * 2007-10-01 2014-02-05 アセンタ セラピューティックス インコーポレイティッド Process for preparing R-gossypol L-phenylalaninol dienamine
KR101477360B1 (en) 2009-06-22 2015-01-02 캐보트 마이크로일렉트로닉스 코포레이션 Cmp compositions and methods for suppressing polysilicon removal rates
EP2460837B1 (en) 2009-07-29 2018-03-21 Teijin Chemicals, Ltd. Polycarbonate/polydiorganosiloxane copolymer
CN101810577B (en) * 2010-05-06 2011-09-07 山东大学 Gossypol intravenous injection fatty emulsion for curing tumors
CN103467538B (en) * 2012-05-29 2015-08-19 武汉大学 Gossypol derivative with anti-HIV activity and preparation method thereof
US9750761B2 (en) * 2014-05-21 2017-09-05 University Of Rochester LDH inhibitors as treatment for fibrosis and fibrotic-related disorders
US20220162561A1 (en) * 2019-04-04 2022-05-26 Nissan Chemical Corporation Composition for promoting secretion of extracellular vesicles
CN110559449B (en) * 2019-10-22 2022-09-02 长治医学院 Polygossypol prodrug micelle and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260327A (en) * 1985-10-02 1993-11-09 Sloan-Kettering Institute For Cancer Research Methods for inhibiting the proliferation of brain and hepatic metastases by using lonidamine
US5026726A (en) * 1989-12-11 1991-06-25 The University Of New Mexico Gossylic iminolactones and gossylic lactones and their anti-viral activities
US5385936A (en) * 1990-07-12 1995-01-31 The United States Of America As Represented By The Secretary Of The Department Of The Health And Human Services Gossypol acetic acid for the treatment of cancer
US5936120A (en) * 1997-12-10 1999-08-10 University Of New Mexico Deoxygossylic compounds
US5780675A (en) * 1995-04-28 1998-07-14 The University Of New Mexico Deoxygossylic compounds
CN1078462C (en) * 1997-07-09 2002-01-30 辛国芳 Stype using gossypol (and) its derivative as active component and use

Also Published As

Publication number Publication date
CN100490791C (en) 2009-05-27
US20020137801A1 (en) 2002-09-26
US6608107B2 (en) 2003-08-19
JP2005502579A (en) 2005-01-27
WO2002047673A3 (en) 2003-01-03
EP1343487A2 (en) 2003-09-17
CN1529590A (en) 2004-09-15
MY134562A (en) 2007-12-31
WO2002047673A2 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2778801A (en) Antisense compositions and methods
AU2002230888A1 (en) Methods and compositions to treat conditions associated with neovascularization
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AUPQ419099A0 (en) Novel compositions and methods
AU2001239947A1 (en) Methods and compositions for regulating adipocytes
AU2001268659A1 (en) Water treatment compositions
AUPR105400A0 (en) Processes and compositions for water treatment
AU3731400A (en) Methods and compositions useful in inhibiting apoptosis
AU2001234437A1 (en) Deicing compositions and methods of use
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU2001293189A1 (en) Compositions and methods for regulating apoptosis
GB9920678D0 (en) Sanitising compositions and methods
AU2002210575A1 (en) Novel medicament compositions based on anticholinergics and corticosteroids
AU2002229616A1 (en) Improvements in and relating to the distribution of content
AU2002241911A1 (en) Methods to treat autoimmune and inflammatory conditions
AU2001229597A1 (en) Compositions and methods to treat neurodegenerative disorders
AU2002365936A1 (en) Compositions and methods to treat gastrointestinal disorders
EP1409507A4 (en) Compositions, methods and kits relating to remodelin
AU2001247471A1 (en) Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones
AU2003263988A1 (en) Methods and compositions to treat conditions associated with neovascularization
AU2002366809A1 (en) Syn3 compositions and methods
AU2001266648A1 (en) Kits and methods for optimizing the efficacy of chondroprotective compositions
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU2001261738A1 (en) Compositions and methods for promoting immunosuppression
AU3347300A (en) Desmethylsildenafil compositions and methods